Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement

Woo, P., Wilkinson, N., Prieur, A-M., Southwood, T., Leone, V., Livermore, P., Wythe, H., Thomson, D. and Kishimoto, T. (2005) Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Research and Therapy, 7 (6). ISSN 1478-6354
Copy

picture_as_pdf
901524.pdf

View Download

EndNote BibTeX Reference Manager Refer Atom Dublin Core OpenURL ContextObject in Span METS HTML Citation MODS MPEG-21 DIDL ASCII Citation OpenURL ContextObject Data Cite XML RIOXX2 XML
Export

Downloads
?